Search results
Results from the WOW.Com Content Network
Included here are companies engaged not only in pharmaceutical development, but also supply chain management and device development, including compounding pharmacies. Firms with no marketed products but which are working on pharmaceutical development as well as mature firms with a post-marketed portfolios have been included here.
This is a list of notable corporations headquartered in Los Angeles County, California. The table is arranged alphabetically by company. The table is arranged alphabetically by company. This is a dynamic list and may never be able to satisfy particular standards for completeness.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Bayer initially opened negotiations with an offer of $125 per Monsanto share, however management felt this undervalued the company. [22] 11 2018 Takeda Pharmaceutical: Shire: 61 74 Second bid, unanimously rejected by the Shire Board, who concluded that it significantly undervalue the company, its growth prospects as well as pipeline. [24] 12 2018
Although the software company is based in San Francisco, it has a significant number of employees in the Los Angeles area. The company will provide 24/7 immediate assistance for all employees ...
CytRx Corp. is a biopharmaceutical research and development oncology company based in Los Angeles, California. The CytRx oncology pipeline includes clinical trials involving their lead drug aldoxorubicin. Aldoxorubicin (formerly INNO-206) is a modified form of doxorubicin, the popular anthracycline chemotherapeutic agent known as "red death".
This is a list of current and former companies based in the San Francisco Bay Area, broken down by type of business. Fortune 500 rankings are indicated in parentheses. As of 2020, 38 Fortune 500 companies had headquarters in the San Francisco Bay Area. [1]
In 2017, the Los Angeles Times wrote that PBMs cause an inflation in drug costs, especially within the area of diabetes drugs. [51] United States Secretary of Health and Human Services Alex Azar stated regarding PBMs, "Everybody wins when list prices rise, except for the patient. It’s rather a startling and perverse system that has evolved ...